These findings suggest that downregulation of Lilrb4 exacerbates the inflammatory process, and targeting Lilrb4 or its associated pathways may be an effective strategy for mitigating inflammation-induced injury in ALI. This evidence concerns the gene LILRB4 and acute respiratory distress syndrome.